CA2290743A1 - Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering - Google Patents

Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering Download PDF

Info

Publication number
CA2290743A1
CA2290743A1 CA002290743A CA2290743A CA2290743A1 CA 2290743 A1 CA2290743 A1 CA 2290743A1 CA 002290743 A CA002290743 A CA 002290743A CA 2290743 A CA2290743 A CA 2290743A CA 2290743 A1 CA2290743 A1 CA 2290743A1
Authority
CA
Canada
Prior art keywords
interpenetrating
polymer
semi
solutions
networks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002290743A
Other languages
French (fr)
Other versions
CA2290743C (en
Inventor
Robert S. Langer
Jennifer H. Elisseeff
Derek Sims
Kristi Anseth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
University of Technology Corp
Massachusetts Institute of Technology
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2290743A1 publication Critical patent/CA2290743A1/en
Application granted granted Critical
Publication of CA2290743C publication Critical patent/CA2290743C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3852—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S525/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S525/903—Interpenetrating network
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S525/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S525/937—Utility as body contact e.g. implant, contact lens or I.U.D.

Abstract

Compositions for tissue engineering and drug delivery have been developed based on solutions of two or more polymers which form semi-interpenetrating or interpenetrating polymer networks upon exposure to active species following injection at a site in a patient in need thereof.
The polymers crosslink to themselves but not to each other; semi-interpenetrating networks are formed when only one of the polymers crosslink. The resulting viscous solutions retain the biologically active molecules or cells at the site of injection until release or tissue formation, respectfully, occurs. As a result of studies conducted with polymer-cell suspensions forming interpenetrating polymer networks, it has been determined that polymer solutions can be formulated wherein the active species is provided by exposure of the polymer solution to an exogenous source of active species, typically electromagnetic radiation, preferably light. Studies demonstrate that light will penetrate through skin, body fluids (such as synovial fluid) and membranes and polymerize the polymer solutions. The polymer solutions can be crosslinked ionically or covalently, to form a hydrogel, semi-interpenetrating polymer network or an interpenetrating polymer network.
CA002290743A 1997-05-23 1998-05-22 Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering Expired - Fee Related CA2290743C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/862,740 US6224893B1 (en) 1997-04-11 1997-05-23 Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
US08/862,740 1997-05-23
PCT/US1998/010626 WO1998052543A1 (en) 1997-05-23 1998-05-22 Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering

Publications (2)

Publication Number Publication Date
CA2290743A1 true CA2290743A1 (en) 1998-11-26
CA2290743C CA2290743C (en) 2009-10-20

Family

ID=25339213

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002290743A Expired - Fee Related CA2290743C (en) 1997-05-23 1998-05-22 Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering

Country Status (8)

Country Link
US (1) US6224893B1 (en)
EP (1) EP1011633A1 (en)
JP (1) JP4343274B2 (en)
KR (1) KR100537907B1 (en)
AU (1) AU726890B2 (en)
CA (1) CA2290743C (en)
NZ (1) NZ501339A (en)
WO (1) WO1998052543A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007028258A3 (en) * 2005-09-09 2007-11-08 Ottawa Health Research Inst Interpenetrating networks, and related methods and compositions

Families Citing this family (162)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
US5837752A (en) * 1997-07-17 1998-11-17 Massachusetts Institute Of Technology Semi-interpenetrating polymer networks
US6331166B1 (en) * 1998-03-03 2001-12-18 Senorx, Inc. Breast biopsy system and method
US6660301B1 (en) * 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
EP1059943B1 (en) * 1998-03-06 2004-12-01 Biosepra Medical Inc. Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
US6376742B1 (en) * 1999-02-17 2002-04-23 Richard J. Zdrahala In vivo tissue engineering with biodegradable polymers
US6372494B1 (en) 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US7039453B2 (en) * 2000-02-08 2006-05-02 Tarun Mullick Miniature ingestible capsule
US7338657B2 (en) * 2001-03-15 2008-03-04 Biosphere Medical, Inc. Injectable microspheres for tissue construction
EP1274472A2 (en) 2000-03-20 2003-01-15 Biosphere Medical, Inc. Injectable and swellable microspheres for tissue bulking
US6436424B1 (en) 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
KR100714742B1 (en) * 2000-07-03 2007-05-07 가부시키가이샤 재팬 티슈 엔지니어링 Base material for tissue reconstruction, transplant material and methods of the same
US7625580B1 (en) * 2000-11-28 2009-12-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
US20070082052A1 (en) * 2001-02-23 2007-04-12 Bonassar Lawrence J Tympanic membrane repair constructs
AU2002252025A1 (en) * 2001-02-23 2002-09-12 University Of Massachusetts Injection molding of living tissues
US6878384B2 (en) * 2001-03-13 2005-04-12 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
WO2002076288A2 (en) 2001-03-27 2002-10-03 Board Of Regents The University Of Texas System Biodegradable, electrically conductiong polymer for tissue engineering applications
US7029838B2 (en) 2001-03-30 2006-04-18 Arizona Board Of Regents On Behalf Of The University Of Arizona Prevascularized contructs for implantation to provide blood perfusion
US7371258B2 (en) 2001-10-26 2008-05-13 St. Jude Medical, Inc. Valved prosthesis with porous substrate
WO2003053216A2 (en) * 2001-12-06 2003-07-03 University Of Washington Biodegradable, porous structures useful for growing living tissue, and methods of manufacture
US20070026518A1 (en) * 2005-03-29 2007-02-01 The Regents Of The University Of California Controlling stem cell destiny with tunable matrices
US7985601B2 (en) * 2002-03-08 2011-07-26 The Regents Of The University Of California Tunable, semi-interpenetrating polymer networks (sIPNS) for medicine and biotechnology
US8298606B2 (en) 2002-03-08 2012-10-30 The Regents Of The University Of California Methods and compositions for stabilizing the myocardium
EP1499890B1 (en) * 2002-05-07 2010-04-28 The Research Foundation of State University of New York High throughput method to identify biomolecule delivery formulations
US20040106896A1 (en) * 2002-11-29 2004-06-03 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
WO2004000103A2 (en) * 2002-06-24 2003-12-31 Noyes William R Fillers and methods for displacing tissues to improve radiological outcomes
US7862831B2 (en) * 2002-10-09 2011-01-04 Synthasome, Inc. Method and material for enhanced tissue-biomaterial integration
US8673333B2 (en) * 2002-09-25 2014-03-18 The Johns Hopkins University Cross-linked polymer matrices, and methods of making and using same
US20050069572A1 (en) * 2002-10-09 2005-03-31 Jennifer Elisseeff Multi-layered polymerizing hydrogels for tissue regeneration
US20060140914A1 (en) * 2002-10-31 2006-06-29 The General Hospital Corporation Repairing or replacing tissues or organs
DE10312144B4 (en) * 2003-03-13 2006-12-14 Technische Universität Dresden Carrier material for tissue and cell culture and the production of implant materials
GB0307011D0 (en) * 2003-03-27 2003-04-30 Regentec Ltd Porous matrix
US7241455B2 (en) * 2003-04-08 2007-07-10 Boston Scientific Scimed, Inc. Implantable or insertable medical devices containing radiation-crosslinked polymer for controlled delivery of a therapeutic agent
US7279174B2 (en) * 2003-05-08 2007-10-09 Advanced Cardiovascular Systems, Inc. Stent coatings comprising hydrophilic additives
US7927599B2 (en) 2003-09-08 2011-04-19 Ethicon, Inc. Chondrocyte therapeutic delivery system
US7897384B2 (en) * 2003-09-08 2011-03-01 Ethicon, Inc. Chondrocyte therapeutic delivery system
US8257963B2 (en) * 2007-06-01 2012-09-04 Depuy Mitek, Inc. Chondrocyte container and method of use
WO2005041987A1 (en) * 2003-10-29 2005-05-12 Gentis, Inc. Polymerizable emulsions for tissue engineering
US20050100712A1 (en) * 2003-11-12 2005-05-12 Simmons Blake A. Polymerization welding and application to microfluidics
ES2403357T3 (en) 2003-12-11 2013-05-17 Isto Technologies Inc. Particle Cartilage System
EP2289567A3 (en) * 2003-12-22 2011-06-22 Regentis Biomaterials Ltd. Matrix comprising naturally-occurring crosslinked protein backbone
US7842667B2 (en) * 2003-12-22 2010-11-30 Regentis Biomaterials Ltd. Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
GB0329907D0 (en) * 2003-12-23 2004-01-28 Innomed Ltd Compositions
DE102004019241A1 (en) * 2004-04-16 2005-11-03 Cellmed Ag Injectable cross-linked and uncrosslinked alginates and their use in medicine and aesthetic surgery
JP5255274B2 (en) * 2004-07-06 2013-08-07 スリーディー マトリックス， インコーポレイテッド Purified amphiphilic peptide composition and use thereof
US8512730B2 (en) 2004-07-12 2013-08-20 Isto Technologies, Inc. Methods of tissue repair and compositions therefor
US7625198B2 (en) 2004-08-11 2009-12-01 Cornell Research Foundation, Inc. Modular fabrication systems and methods
US7909867B2 (en) * 2004-10-05 2011-03-22 The Board Of Trustees Of The Leland Stanford Junior University Interpenetrating polymer network hydrogel corneal prosthesis
US20090088846A1 (en) 2007-04-17 2009-04-02 David Myung Hydrogel arthroplasty device
US7857447B2 (en) * 2004-10-05 2010-12-28 The Board Of Trustees Of The Leland Stanford Junior University Interpenetrating polymer network hydrogel contact lenses
US7857849B2 (en) * 2004-10-05 2010-12-28 The Board Of Trustees Of The Leland Stanford Junior Iniversity Artificial corneal implant
US8821583B2 (en) * 2004-10-05 2014-09-02 The Board Of Trustees Of The Leland Stanford Junior University Interpenetrating polymer network hydrogel
US7235592B2 (en) * 2004-10-12 2007-06-26 Zimmer Gmbh PVA hydrogel
KR20080016780A (en) * 2004-11-24 2008-02-22 테라킨 리미티드 An implant for intraocular drug delivery
WO2006062518A2 (en) 2004-12-08 2006-06-15 Interpore Spine Ltd. Continuous phase composite for musculoskeletal repair
WO2006089267A2 (en) * 2005-02-18 2006-08-24 Synthasome Inc. Synthetic structure for soft tissue repair
WO2006089119A2 (en) * 2005-02-18 2006-08-24 Cartilix, Inc. Biological adhesive
US8017139B2 (en) * 2005-02-23 2011-09-13 Zimmer Technology, Inc. Blend hydrogels and methods of making
US20060258788A1 (en) * 2005-05-13 2006-11-16 Scott Coggins Polymeric hydrogel compositions
CN101282652B (en) * 2005-06-02 2013-09-11 亚利桑那董事会（代表亚利桑那大学） Prevascularized devices and related methods
US7968614B2 (en) * 2005-06-15 2011-06-28 Surmodics, Inc. Macromer composition including light activated initiator
US20070036842A1 (en) * 2005-08-15 2007-02-15 Concordia Manufacturing Llc Non-woven scaffold for tissue engineering
EP1916964A4 (en) 2005-08-26 2015-11-04 Zimmer Inc Implants and methods for repair, replacement and treatment of joint disease
US20070098799A1 (en) * 2005-10-28 2007-05-03 Zimmer, Inc. Mineralized Hydrogels and Methods of Making and Using Hydrogels
WO2007067697A2 (en) 2005-12-07 2007-06-14 Zimmer, Inc. Methods of bonding or modifying hydrogels using irradiation
US20070141108A1 (en) * 2005-12-20 2007-06-21 Zimmer, Inc. Fiber-reinforced water-swellable articles
EP1801135B1 (en) * 2005-12-22 2010-09-29 Zimmer Inc. Perfluorocyclobutane crosslinked hydrogels
US20070191848A1 (en) * 2006-02-01 2007-08-16 Zimmer Technology, Inc. Hydrogel bone plate spacer
US20070212385A1 (en) * 2006-03-13 2007-09-13 David Nathaniel E Fluidic Tissue Augmentation Compositions and Methods
US8110242B2 (en) * 2006-03-24 2012-02-07 Zimmer, Inc. Methods of preparing hydrogel coatings
ITPD20060203A1 (en) * 2006-05-22 2007-11-23 Univ Degli Studi Trieste HYDROGELS OF POLYSACCHARID MIXTURES FOR TISSUE ENGINEERING AND THE VEHICLE OF ACTIVE COMPOUNDS
CA2655026C (en) 2006-06-15 2016-08-02 Microvention, Inc. Embolization device constructed from expansible polymer
US20080003205A1 (en) * 2006-06-26 2008-01-03 University Of Massachusetts Tympanic Membrane Repair Constructs
EP2081984B1 (en) * 2006-11-03 2012-07-04 PTT Holding Aps A method of producing an article comprising an interpenetrating polymer network (ipn) and an article comprising an ipn
EP2143450B1 (en) 2006-11-29 2015-03-18 National University Corporation Hokkaido University A hydrogel for use as bone filler inducing cartilage or cartilage tissue regeneration
US7935363B2 (en) 2006-12-12 2011-05-03 Synthasome, Inc. Composite material for tissue repair
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
WO2008100617A1 (en) * 2007-02-16 2008-08-21 The Board Of Trustees Of The Leland Stanford Junior University Strain-hardened interpenetrating polymer network hydrogel
US20090012629A1 (en) 2007-04-12 2009-01-08 Isto Technologies, Inc. Compositions and methods for tissue repair
EP3628275B1 (en) * 2007-04-17 2023-03-01 The Board of Trustees of the Leland Stanford Junior University Hydrogel arthroplasty device
WO2008131123A1 (en) * 2007-04-17 2008-10-30 Board Of Regents, The University Of Texas System Recognitive hydrogel
US20080287633A1 (en) * 2007-05-18 2008-11-20 Drumheller Paul D Hydrogel Materials
US7731988B2 (en) * 2007-08-03 2010-06-08 Zimmer, Inc. Multi-polymer hydrogels
US20090043398A1 (en) * 2007-08-09 2009-02-12 Zimmer, Inc. Method of producing gradient articles by centrifugation molding or casting
US8062739B2 (en) * 2007-08-31 2011-11-22 Zimmer, Inc. Hydrogels with gradient
US7947784B2 (en) * 2007-11-16 2011-05-24 Zimmer, Inc. Reactive compounding of hydrogels
FR2924615B1 (en) 2007-12-07 2010-01-22 Vivacy Lab HYDROGEL COHESIVE BIODEGRADABLE.
US8563066B2 (en) 2007-12-17 2013-10-22 New World Pharmaceuticals, Llc Sustained release of nutrients in vivo
US8034362B2 (en) * 2008-01-04 2011-10-11 Zimmer, Inc. Chemical composition of hydrogels for use as articulating surfaces
EP2252686B1 (en) 2008-02-11 2017-10-11 The Johns Hopkins University Compositions and methods for implantation of adipose tissue and adipose tissue products
US20090240337A1 (en) * 2008-03-21 2009-09-24 David Myung Methods, Devices and Compositions for Adhering Hydrated Polymer Implants to Bone
WO2009124388A1 (en) * 2008-04-09 2009-10-15 Mcmaster University Hydrogel with covalently crosslinked core
GB2459438B (en) * 2008-04-10 2010-10-06 Kythera Biopharmaceuticals Inc Systems and methods for transdermal photo-polymerization
US8128983B2 (en) * 2008-04-11 2012-03-06 Abbott Cardiovascular Systems Inc. Coating comprising poly(ethylene glycol)-poly(lactide-glycolide-caprolactone) interpenetrating network
EP2291524A2 (en) 2008-04-24 2011-03-09 Medtronic, Inc Rehydratable thiolated polysaccharide particles and sponge
JP5833919B2 (en) * 2008-04-24 2015-12-16 メドトロニック，インコーポレイテッド Protective gel based on chitosan and oxidized polysaccharide
AU2009240513B2 (en) 2008-04-24 2015-03-26 Medtronic, Inc. Chitosan-containing protective composition
WO2009132229A2 (en) 2008-04-24 2009-10-29 Medtronic, Inc. Cold ionizing radiation sterilization
US8586086B2 (en) * 2008-05-29 2013-11-19 Politecnico Di Milano Hydrogel capable of containing and conveying cells
ITMI20082037A1 (en) * 2008-11-17 2010-05-18 Milano Politecnico HYDROGEL SUITABLE FOR CONTAINING AND CARRYING CELLS
AU2009268687A1 (en) * 2008-07-07 2010-01-14 Biomimedica, Inc Hydrophilic interpenetrating polymer networks derived from hydrophobic polymers
US20120209396A1 (en) 2008-07-07 2012-08-16 David Myung Orthopedic implants having gradient polymer alloys
KR20110040969A (en) 2008-08-05 2011-04-20 바이오미메디카, 인코포레이티드 Polyurethane-grafted hydrogels
US10010500B2 (en) * 2008-08-21 2018-07-03 Biomet Manufacturing, Llc Ceramic implants affording controlled release of active materials
EP3470093B1 (en) 2008-10-06 2020-08-19 3-D Matrix Ltd. Tissue plug
KR20220112862A (en) 2008-11-12 2022-08-11 인리젠 Isolated renal cells and uses thereof
US9597430B2 (en) * 2009-07-31 2017-03-21 Synthasome, Inc. Synthetic structure for soft tissue repair
CN101623515A (en) * 2009-07-31 2010-01-13 清华大学 Method for preparing complicated tissue organ precursor with multilayer structure
US20110081398A1 (en) * 2009-10-01 2011-04-07 Tyco Healthcare Group Lp Multi-mechanism surgical compositions
EP2498764B1 (en) 2009-11-09 2017-09-06 Spotlight Technology Partners LLC Fragmented hydrogels
CA2780294C (en) 2009-11-09 2018-01-16 Spotlight Technology Partners Llc Polysaccharide based hydrogels
IN2012DN05177A (en) 2009-12-15 2015-10-23 Incept Llc
WO2011075742A1 (en) * 2009-12-18 2011-06-23 Biomimedica, Inc. Method, device, and system for shaving and shaping of a joint
EP2542249A4 (en) 2010-03-05 2013-08-07 Tissue Genesis Inc Methods and compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells
WO2011112996A2 (en) * 2010-03-12 2011-09-15 Surmodics, Inc. Injectable drug delivery system
AU2011247984B2 (en) * 2010-05-07 2015-04-30 University Of North Carolina At Chapel Hill Method of engrafting cells from solid tissues
HUE058155T2 (en) 2010-05-12 2022-07-28 Prokidney Bioactive renal cells
WO2011156642A1 (en) 2010-06-11 2011-12-15 Tengion, Inc. Erythropoietin-expressing adipose cell populations
EP2609154B1 (en) 2010-08-27 2020-04-22 Hyalex Orthopaedics, Inc. Hydrophobic and hydrophilic interpenetrating polymer networks derived from hydrophobic polymers and methods of preparing the same
US20120083767A1 (en) * 2010-10-01 2012-04-05 The Johns Hopkins University Implantable bioreactor for delivery of paracrine factors
AU2011326767B2 (en) 2010-11-10 2016-02-11 Prokidney Injectable formulations for organ augmentation
US9408881B2 (en) 2010-11-12 2016-08-09 Allergan, Inc. Topical composition
US9023092B2 (en) 2011-08-23 2015-05-05 Anthony Natale Endoscopes enhanced with pathogenic treatment
WO2013028833A1 (en) 2011-08-23 2013-02-28 Anthony Natale Systems and methods for treating pathogenic infection
US20130103157A1 (en) 2011-10-03 2013-04-25 Lampros Kourtis Polymeric adhesive for anchoring compliant materials to another surface
ES2689265T3 (en) 2011-11-04 2018-11-12 Inregen Drug screening and potency tests
KR20140059238A (en) * 2011-11-11 2014-05-15 미바 메디컬 아이엔시. Injectable filler
EP3335673A1 (en) 2011-11-21 2018-06-20 Biomimedica, Inc Systems for anchoring orthopaedic implants to bone
CN102512261B (en) * 2011-12-28 2015-01-21 清华大学 Preparation method for complex organ precursors on basis of combination molds
WO2013103956A1 (en) * 2012-01-05 2013-07-11 President And Fellows Of Harvard College Interpenetrating networks with covalent and ionic crosslinks
EP2869903B1 (en) 2012-07-06 2018-11-28 3-D Matrix Ltd. Fill-finish process for peptide solutions
PL3567099T3 (en) 2012-10-24 2021-11-29 Prokidney Renal cell populations and uses thereof
US10245306B2 (en) 2012-11-16 2019-04-02 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
KR102225312B1 (en) 2013-05-08 2021-03-10 인리젠 Organoids comprising isolated renal cells and uses thereof
JP6357156B2 (en) * 2013-09-02 2018-07-11 テルモ株式会社 Medical device and manufacturing method thereof
EP3071236A4 (en) 2013-11-20 2017-05-24 Trustees of Boston University Injectable tissue supplement
US9512279B2 (en) * 2013-12-18 2016-12-06 Universite Cegy-Pontoise Interpenetrating polymer network
ES2712608T3 (en) 2014-03-10 2019-05-14 3 D Matrix Ltd Self-assembling peptides for the treatment of pulmonary bullae
JP6684719B2 (en) 2014-03-10 2020-04-22 株式会社スリー・ディー・マトリックス Sterilization and filtration of peptide compositions
CA2939696C (en) 2014-03-10 2023-01-10 3-D Matrix, Ltd. Self-assembling peptide compositions
EP3137124B1 (en) 2014-04-29 2019-01-09 Microvention, Inc. Polymers including active agents
US10179191B2 (en) 2014-10-09 2019-01-15 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
TW201625754A (en) * 2014-11-21 2016-07-16 艾倫塔斯有限公司 Single-component, storage-stable, curable silicone composition
WO2016100355A1 (en) * 2014-12-15 2016-06-23 The Regents Of The University Of Colorado, A Body Corporate Biocompatible hydrogels, systems including the hydrogels, and methods of using and forming same
WO2016201250A1 (en) * 2015-06-11 2016-12-15 Microvention, Inc. Expansile device for implantation
US11077228B2 (en) 2015-08-10 2021-08-03 Hyalex Orthopaedics, Inc. Interpenetrating polymer networks
US20170136144A1 (en) 2015-11-12 2017-05-18 John C. Herr Compositions and methods for vas-occlusive contraception
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
WO2017139765A1 (en) 2016-02-12 2017-08-17 Rodan & Fields, Llc Moisturizing compositions and uses thereof
US10722443B2 (en) * 2016-09-14 2020-07-28 Rodan & Fields, Llc Moisturizing compositions and uses thereof
EP4151661A1 (en) * 2016-03-24 2023-03-22 Takeda Pharmaceutical Company Limited Alginate hydrogel compositions
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
US10751124B2 (en) * 2017-01-05 2020-08-25 Contraline, Inc. Methods for implanting and reversing stimuli-responsive implants
WO2018218060A2 (en) 2017-05-25 2018-11-29 Tdbt Ip Inc. Aseptic printer system including dual-arm mechanism
EP3723726A1 (en) 2017-12-15 2020-10-21 3-D Matrix, Ltd. Surfactant peptide nanostructures and uses in drug delivery
US20210069376A1 (en) * 2017-12-29 2021-03-11 Bef Medical Inc. Composition for regeneration of human fibrous cartilage or elastic cartilage
WO2019200042A1 (en) 2018-04-11 2019-10-17 Trustees Of Boston University Engineered platform to generate 3d cardiac tissues
US10869950B2 (en) 2018-07-17 2020-12-22 Hyalex Orthopaedics, Inc. Ionic polymer compositions
US11318040B2 (en) 2018-11-13 2022-05-03 Contraline, Inc. Systems and methods for delivering biomaterials
CA3144269A1 (en) * 2019-06-19 2020-12-24 Smylio Inc. Stress relaxation resistant orthodontic appliances
WO2023211924A1 (en) * 2022-04-25 2023-11-02 Applied Cardiovascular Solutions, LLC Methods, systems, and devices for the occlusion of the left atrial appendage

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0352912A (en) * 1989-07-19 1991-03-07 Nippon Paint Co Ltd Composite resin particle and production thereof
AU3124793A (en) 1991-10-29 1993-06-07 Clover Consolidated, Limited Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
WO1993017669A1 (en) 1992-02-28 1993-09-16 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5334640A (en) * 1992-04-08 1994-08-02 Clover Consolidated, Ltd. Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods
US5514378A (en) 1993-02-01 1996-05-07 Massachusetts Institute Of Technology Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5900245A (en) 1996-03-22 1999-05-04 Focal, Inc. Compliant tissue sealants
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
AU1051597A (en) 1995-11-09 1997-05-29 University Of Massachusetts Tissue re-surfacing with hydrogel-cell compositions
US5837752A (en) * 1997-07-17 1998-11-17 Massachusetts Institute Of Technology Semi-interpenetrating polymer networks

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007028258A3 (en) * 2005-09-09 2007-11-08 Ottawa Health Research Inst Interpenetrating networks, and related methods and compositions

Also Published As

Publication number Publication date
KR20010012875A (en) 2001-02-26
AU726890B2 (en) 2000-11-23
EP1011633A1 (en) 2000-06-28
JP2002503230A (en) 2002-01-29
CA2290743C (en) 2009-10-20
WO1998052543A1 (en) 1998-11-26
US6224893B1 (en) 2001-05-01
AU7595698A (en) 1998-12-11
KR100537907B1 (en) 2005-12-21
JP4343274B2 (en) 2009-10-14
NZ501339A (en) 2002-02-01

Similar Documents

Publication Publication Date Title
CA2290743A1 (en) Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
Nho et al. Preparation and properties of PVA/PVP hydrogels containing chitosan by radiation
KR100349020B1 (en) Gels Formed by the Interaction of Polyvinylpyrrolidone with Chitosan Derivatives
DK0959873T3 (en) Gel composition and methods
CA2268140A1 (en) Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
EP0742022A4 (en) Biologically compatible hydrogel
US4379864A (en) Polymeric compositions and hydrogels formed therefrom
WO1997005185A3 (en) Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents
AU590565B2 (en) Controlled release delivery system for macromolecules
ES2171186T3 (en) LIQUID DIFFUSION COMPOSITIONS.
AU5242701A (en) Wound gels
AU1507595A (en) Collagen-synthetic polymer matrices prepared using multiple step reaction
DD273200A5 (en) METHOD FOR DISPLAYING HYDROGEL DISPERSES
US20110117198A1 (en) Compositions of semi-interpenetrating polymer network
ES2130450T3 (en) PROCEDURE FOR THE MANUFACTURE OF WATER-SOLUBLE POLYMER DISPERSIONS WITH A HIGH POLYMER PART.
EP3815659A1 (en) Ipn hydrogel for preparation and application
GB2227492A (en) Anionic polymeric hydrogels and a process for making the same
DE59407457D1 (en) BLOCKING THE ADMINISTRATION OF GermS IN HUMAN CELLS
US4692328A (en) Biologically useful polymer preparations
ATE258960T1 (en) ANION-CATION-POLYION COMPLEXES WITH ZWITTERIONIC MONOMER COMPONENT
KR20040039296A (en) Polymeric hydrogel
US4772484A (en) Biologically useful polymer preparations
Firsov et al. Biodegradable implants containing gentamicin: drug release and pharmacokinetics
Mascarenhas Epoxy-based medical grade adhesive hydrogels and nitric oxide releasing polymers
Majkus et al. Employment of hydron polymer antibiotic vehicle in otolaryngology

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20170523

MKLA Lapsed

Effective date: 20170523